These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23240787)

  • 1. Iron complex, dabigatran and toxic epidermal necrolysis syndrome: a case-report.
    Tsoumpris A; Tzimas T; Gkabrelas K; Akritidis N
    J Clin Pharm Ther; 2013 Apr; 38(2):177-8. PubMed ID: 23240787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
    Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
    Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
    Wychowski MK; Kouides PA
    Ann Pharmacother; 2012 Apr; 46(4):e10. PubMed ID: 22496474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    de Rego JA; Goldstein DM
    Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
    Pujol Farriols R; Anglada Oriol M; Formiga Pérez F; Fernández-Sabe N; Mitjavila Vileró F; Vidaller Palacín A
    An Med Interna; 2002 Dec; 19(12):651-2. PubMed ID: 12593038
    [No Abstract]   [Full Text] [Related]  

  • 8. [Legofer--a new approach in the treatment of iron deficiency. Pharmacological and biopharmacological characteristics of legofer (ferric protein succinylate)].
    Akush Ginekol (Sofiia); 2002; 41 Suppl 1():21-3. PubMed ID: 12412350
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
    Boruah PK; Bolesta S; Shetty SM
    Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis due to voriconazole: case report and review.
    Gomulka J; Wilson BD; Joyce JC
    Dermatol Online J; 2014 Sep; 20(9):. PubMed ID: 25244163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature.
    Kakar R; Paugh H; Jaworsky C
    Dermatology; 2013; 227(3):209-13. PubMed ID: 24135381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis.
    Lacy JA
    Nutr Clin Pract; 1991 Feb; 6(1):18-20. PubMed ID: 1775102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive postoperative ecchymosis in a patient taking dabigatran.
    Wagner CA; Oberoi N; Ahluwalia PK
    J Minim Invasive Gynecol; 2013; 20(1):127-30. PubMed ID: 23312256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatologic emergencies.
    Usatine RP; Sandy N
    Am Fam Physician; 2010 Oct; 82(7):773-80. PubMed ID: 20879700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron protein succinylate: preclinical safety assessment.
    Forster R
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):53-60. PubMed ID: 8458676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
    Baruch L; Sherman O
    Ann Pharmacother; 2011 Jul; 45(7-8):e40. PubMed ID: 21712509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of oral iron protein succinylate: a systematic review of three decades of research.
    Martínez Francés A; Leal Martínez-Bujanda J
    Curr Med Res Opin; 2020 Apr; 36(4):613-623. PubMed ID: 31944128
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.